EXMceuticals Inc. (EXM.CN) Research

EXMceuticals Inc. specializes in the development and manufacturing of cannabinoid-derived formulations. The company's primary focus is to match natural, bioactive compounds extracted from the cannabis plant with the specific needs of the nutraceutical, cosmeceutical, therapeutic, and pharmaceutical industries. They produce CBD, a non-intoxicating cannabinoid recognized for its effectiveness against ailments such as acne, anxiety, depression, epilepsy, and neurodegenerative conditions like Parkinson's. Additionally, they produce THC, a psychoactive cannabinoid proven beneficial for pain management, appetite stimulation, anxiety relief, and mitigating chemotherapy side effects. Founded in 2008, the company's head office is located in Quebec, Canada.

Market snapshot

Symbol
EXM.CN
Price
$0.20
Day change
0.00%
Market cap
$15.1M
P/E ratio
-0.81x
52-week range
0.2-0.2
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Peer companies

  • Antibe Therapeutics Inc. (ATE.TO)
  • Ayr Wellness Inc. (AYR-A.CN)
  • Chalice Brands Ltd. (CHAL.CN)
  • CanaFarma Hemp Products Corp. (CNFA.CN)
  • IM Cannabis Corp. (IMCC.CN)
  • LexaGene Holdings Inc. (LXG.V)
  • Marvell Technology, Inc. (MRV.TO)
  • Numinus Wellness Inc. (NUMI.TO)

Open EXMceuticals Inc. (EXM.CN) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.